Andrew Galler
Stock Analyst at Morgan Stanley
(0.52)
# 3,835
Out of 4,711 analysts
28
Total ratings
27.78%
Success rate
-16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Downgrades: Equal-Weight | $74 → $35 | $28.33 | +23.57% | 12 | Dec 13, 2024 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $9.80 | +53.06% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $6.88 | +161.63% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $19.45 | +90.23% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $35.63 | +57.17% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $7.34 | +145.23% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $46.24 | +16.78% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $46.96 | +6.47% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $1.96 | +2,144.90% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $39.39 | +671.77% | 1 | Nov 9, 2021 |
Immunocore Holdings
Dec 13, 2024
Downgrades: Equal-Weight
Price Target: $74 → $35
Current: $28.33
Upside: +23.57%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $9.80
Upside: +53.06%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $6.88
Upside: +161.63%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $19.45
Upside: +90.23%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $35.63
Upside: +57.17%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $7.34
Upside: +145.23%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $46.24
Upside: +16.78%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $46.96
Upside: +6.47%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $1.96
Upside: +2,144.90%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $39.39
Upside: +671.77%